Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2026-05-17 @ 3:59 PM
Study NCT ID:
NCT06549751
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-08-12
First Post:
2024-06-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MT-601 Administered To Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Sponsor:
Marker Therapeutics, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MRKR-22-601-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None